REPORT: New oral medicine reduces COVID-19 hospitalizations and deaths

Medical research company Merck announced Friday that their investigational oral antiviral medicine reduced the number of hospitalized COVID-19 patients. In addition, it reduced deaths as well. Ridgeback Biotherapeutics teamed up on the study Now, the companies are seeking emergency use authorization in the United States. Nearly 1,550 COVID positive patients were a part of the … Read more

>